Plug Power Inc (NASDAQ:PLUG) raised more than anticipated in an offering of 22,600,000 shares of its common stock at $5.50 per share for a total of $124,300,000 in gross proceeds. It was the firm’s largest stock offering. The WSJ’s Money Beat reported that Plug Power Inc (NASDAQ:PLUG) was “a darling of day traders and a…
Shares of Gold Fields Limited (ADR) (NYSE:GFI) have earned an average recommendation of “Hold” from the eleven brokerages that are currently covering the company, Analyst Ratings Net reports. Two research analysts have rated the stock with a sell rating, six have issued a hold rating and two have assigned a buy rating to the company….
Yingli Green Energy Holding Co. Ltd. (ADR) (NYSE:YGE), the largest solar-panel maker, will sell 25 million shares at a 17 percent discount as it raises money to build power plants. The American depositary receipts, which represent one ordinary share, will be sold for $3.50 apiece, the Baoding, China-based company said in a statement today. Yingli…
OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI) shares plunged more than 48% pre-market after the company said results from its Phase 3 SYNERGY trial to add custirsen to standard first-line treatment of docetaxel/prednisone in men with metastatic prostate cancer failed to meet primary endpoints. The stock which was halted from trading ahead of the news, recently changed hands…
Neptune Technologies & Bioressources-Ord (NASDAQ:NEPT) and Acasti Pharma Inc (NASDAQ:ACST), a Neptune subsidiary, Sunday night announced that a final and binding patent infringement settlement and license agreement has been signed with Enzymotec Ltd. and Enzymotec Ltd(NASDAQ:ENZY) that resolves the International Trade Commission’s investigation of infringement of Neptune’s composition of matter patents, related federal court actions initiated by…
The American Despositary Receipts of Teva Pharmaceutical Industries Ltd (ADR)(NYSE:TEVA) edged up in recent pre-market trading on Monday after announcing over the weekend an agreement it has signed with Takeda Pharmaceutical for the marketing and sale of Rasagiline in Japan. Rasagiline is a treatment for Parkinson’s Disease developed by TEVA and has been approved in…
Tech Analysis & Market News